FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3026171640> ?p ?o ?g. }

• W3026171640 abstract "To summarize reported cancer events associated with SGLT-2 inhibitors used in patients with type 2 diabetes mellitus, as well as assess the quality of included reviews.In May 2019, we searched PubMed, Embase and the Cochrane Library for quantitative systematic reviews assessing the safety of SGLT-2 inhibitors. Data were abstracted using a standardized form, and methodological quality was assessed using the AMSTAR 2 tool. Main outcome measures included total cancer events and specific cancers such as breast cancer, bladder cancer, gastrointestinal cancer, prostate cancer, respiratory cancer, renal cancer and skin cancer. Pooled treatment effects from included reviews were summarized for SGLT-2 inhibitors as a class and for individual SGLT-2 inhibitors commonly used worldwide (canagliflozin, dapagliflozin and empagliflozin).We screened 1248 unique citations, of which eight quantitative systematic reviews meta-analysed results from studies reporting the association between an SGLT-2 inhibitor and any cancer. Only one review was rated as high quality according to AMSTAR 2 assessment. In total, data from 170 cancer-related point estimates (PE) were reported. As a class, SGLT-2 inhibitors were not associated with an increased risk of any cancer event versus placebo and active comparators. Most point estimates (7/143) were nonsignificant for individual cancers except for two associations. Empagliflozin was associated with an increased risk of bladder cancer versus placebo and active comparators in two reviews, while canagliflozin appeared protective for gastrointestinal cancer versus placebo and active comparators in one review.It appears that SGLT-2 inhibitors are not associated with an increased risk of total cancer or specific cancers in patients with type 2 diabetes. However, higher quality evidence is needed to derive confident conclusions." @default.
• W3026171640 created "2020-05-29" @default.
• W3026171640 creator A5003890249 @default.
• W3026171640 creator A5021684184 @default.
• W3026171640 creator A5034394823 @default.
• W3026171640 creator A5044787082 @default.
• W3026171640 creator A5056807060 @default.
• W3026171640 creator A5059327282 @default.
• W3026171640 date "2020-05-20" @default.
• W3026171640 modified "2023-10-15" @default.
• W3026171640 title "The association of sodium‐glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews" @default.
• W3026171640 cites W1664963969 @default.
• W3026171640 cites W1883655199 @default.
• W3026171640 cites W1974864689 @default.
• W3026171640 cites W2044394324 @default.
• W3026171640 cites W2045457068 @default.
• W3026171640 cites W2100796772 @default.
• W3026171640 cites W2146264128 @default.
• W3026171640 cites W2301210108 @default.
• W3026171640 cites W2475260156 @default.
• W3026171640 cites W2550194700 @default.
• W3026171640 cites W2551481457 @default.
• W3026171640 cites W2619772777 @default.
• W3026171640 cites W2739126694 @default.
• W3026171640 cites W2756578555 @default.
• W3026171640 cites W2764152916 @default.
• W3026171640 cites W2795075943 @default.
• W3026171640 cites W2798054615 @default.
• W3026171640 cites W2884577405 @default.
• W3026171640 cites W2902044664 @default.
• W3026171640 cites W2936553968 @default.
• W3026171640 cites W2939222610 @default.
• W3026171640 doi "https://doi.org/10.1002/edm2.145" @default.
• W3026171640 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7375059" @default.
• W3026171640 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32704566" @default.
• W3026171640 hasPublicationYear "2020" @default.
• W3026171640 type Work @default.
• W3026171640 sameAs 3026171640 @default.
• W3026171640 citedByCount "18" @default.
• W3026171640 countsByYear W30261716402019 @default.
• W3026171640 countsByYear W30261716402021 @default.
• W3026171640 countsByYear W30261716402022 @default.
• W3026171640 countsByYear W30261716402023 @default.
• W3026171640 crossrefType "journal-article" @default.
• W3026171640 hasAuthorship W3026171640A5003890249 @default.
• W3026171640 hasAuthorship W3026171640A5021684184 @default.
• W3026171640 hasAuthorship W3026171640A5034394823 @default.
• W3026171640 hasAuthorship W3026171640A5044787082 @default.
• W3026171640 hasAuthorship W3026171640A5056807060 @default.
• W3026171640 hasAuthorship W3026171640A5059327282 @default.
• W3026171640 hasBestOaLocation W30261716401 @default.
• W3026171640 hasConcept C121608353 @default.
• W3026171640 hasConcept C126322002 @default.
• W3026171640 hasConcept C134018914 @default.
• W3026171640 hasConcept C142724271 @default.
• W3026171640 hasConcept C143998085 @default.
• W3026171640 hasConcept C17744445 @default.
• W3026171640 hasConcept C189708586 @default.
• W3026171640 hasConcept C199539241 @default.
• W3026171640 hasConcept C204787440 @default.
• W3026171640 hasConcept C27081682 @default.
• W3026171640 hasConcept C2775887513 @default.
• W3026171640 hasConcept C2776478404 @default.
• W3026171640 hasConcept C2777180221 @default.
• W3026171640 hasConcept C2777422806 @default.
• W3026171640 hasConcept C2777451236 @default.
• W3026171640 hasConcept C2779473830 @default.
• W3026171640 hasConcept C2780192828 @default.
• W3026171640 hasConcept C2780352672 @default.
• W3026171640 hasConcept C555293320 @default.
• W3026171640 hasConcept C71924100 @default.
• W3026171640 hasConcept C95190672 @default.
• W3026171640 hasConceptScore W3026171640C121608353 @default.
• W3026171640 hasConceptScore W3026171640C126322002 @default.
• W3026171640 hasConceptScore W3026171640C134018914 @default.
• W3026171640 hasConceptScore W3026171640C142724271 @default.
• W3026171640 hasConceptScore W3026171640C143998085 @default.
• W3026171640 hasConceptScore W3026171640C17744445 @default.
• W3026171640 hasConceptScore W3026171640C189708586 @default.
• W3026171640 hasConceptScore W3026171640C199539241 @default.
• W3026171640 hasConceptScore W3026171640C204787440 @default.
• W3026171640 hasConceptScore W3026171640C27081682 @default.
• W3026171640 hasConceptScore W3026171640C2775887513 @default.
• W3026171640 hasConceptScore W3026171640C2776478404 @default.
• W3026171640 hasConceptScore W3026171640C2777180221 @default.
• W3026171640 hasConceptScore W3026171640C2777422806 @default.
• W3026171640 hasConceptScore W3026171640C2777451236 @default.
• W3026171640 hasConceptScore W3026171640C2779473830 @default.
• W3026171640 hasConceptScore W3026171640C2780192828 @default.
• W3026171640 hasConceptScore W3026171640C2780352672 @default.
• W3026171640 hasConceptScore W3026171640C555293320 @default.
• W3026171640 hasConceptScore W3026171640C71924100 @default.
• W3026171640 hasConceptScore W3026171640C95190672 @default.
• W3026171640 hasIssue "3" @default.
• W3026171640 hasLocation W30261716401 @default.
• W3026171640 hasLocation W30261716402 @default.
• W3026171640 hasLocation W30261716403 @default.
• W3026171640 hasLocation W30261716404 @default.
• W3026171640 hasOpenAccess W3026171640 @default.
• W3026171640 hasPrimaryLocation W30261716401 @default.

• next